MRC Holland Launches Carrier Screening Panel for 26 Inherited Disorders
The new panel detects copy number variants and selected genetic variants, including those in complex genomic regions that can be difficult to assess with routine sequencing.
The new panel detects copy number variants and selected genetic variants, including those in complex genomic regions that can be difficult to assess with routine sequencing.
Thermo Fisher Scientific has introduced value-priced AmpSure Universal SYBR Green and Probe Master Mixes, designed for compatibility with existing qPCR instruments and workflows, according to the company.
The workflow eliminates separate qPCR quantification and manual normalization steps, preparing sequencing-ready libraries in approximately 2.5 hours.
Diatech Pharmacogenetics has acquired SensoQuest and launched the Labcycler PCR thermal cycler, expanding into laboratory instrumentation with a platform rated for up to 600,000 cycles and manufactured in Italy.
Read MoreAbbott’s Oncodetect MRD test showed a 30% sensitivity improvement over existing methods for detecting colorectal cancer recurrence post-surgery, according to clinical data presented at ESMO 2026.
Read MoreThe acquisition adds a saliva assay for periodontal pathogen detection, extending the CLIA-certified laboratory’s services to dental practices.
Read MoreThe 20-minute multiplex test delivers eight results covering bacterial vaginosis, Candida species, and trichomoniasis from clinician- or self-collected swabs.
Read MoreBiodesix, in collaboration with Bio-Rad and Thermo Fisher Scientific, is advancing decentralized tumor-informed and tumor-naïve MRD assays designed for clinical labs, with validation underway at Memorial Sloan Kettering Cancer Center.
Read MoreThe partnership will allow clinical laboratories to integrate multiple Panther Systems into automated workflows designed to increase testing capacity and improve sample tracking.
Read MoreGene by Gene will provide whole-genome sequencing for Children’s Mercy’s Genomic Answers for Kids program, supporting the analysis of nearly 100,000 genomes from 30,000 families affected by pediatric rare diseases.
Read MoreGuardant Health will present 25 abstracts at ESMO 2026, highlighting new data on ctDNA liquid biopsy for cancer monitoring, including MRD surveillance and therapy resistance in lung, colorectal, and gastric cancers.New research examines how circulating tumor DNA testing could help detect cancer recurrence, track treatment response, and identify resistance across multiple cancer types.
Read MoreThe molecular test can identify multiple causes of fever from a single blood sample in about an hour, helping healthcare workers diagnose infections and respond to outbreaks more quickly.
Read MoreThe project will analyze immune cells from blood samples to help researchers understand how differences in the immune system influence disease risk, progression, and treatment response.
Read MoreNew software allows researchers to examine repeat expansions associated with up to 23 disease-related genetic regions in a single run.
Read MoreDelve Bio has launched Delve Detect Plasma, a blood-based mNGS assay capable of detecting over 68,000 pathogens from a single blood draw, with next-day results.
Read MoreMayo Clinic Laboratories and Pathology Asia Holdings have announced a strategic investment to expand regional access to molecular and genomic diagnostics in Southeast Asia, Australia, and New Zealand.
Read MoreUNC and Tulane researchers have developed a CRISPR-based microfluidic assay that identifies 15 nontuberculous mycobacteria species directly from clinical specimens in 3.5 hours, with over 97% sensitivity, according to a recent study.
Read MoreA multicenter study led by Children’s Hospital Colorado finds that skin biopsy fibroblast assays can help diagnose primary mitochondrial diseases, potentially reducing the need for invasive muscle and liver biopsies.
Read More